BioCryst Pharmaceuticals BCRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$721.81M-394% | $245.85M+1,806% | $12.9M+154% | $5.09M+15,791% | $32K+100% | ||
| $461K+17.0% | $394K+17.6% | $335K+1.8% | $329K-0.6% | $331K+7.1% | ||
| $16.03M-32.6% | $23.79M+27.9% | $18.6M-12.7% | $21.3M-0.3% | $21.37M+0.1% | ||
| -$61.79M-121% | $291.96M+601% | $41.62M+0.8% | $41.3M+250% | -$27.52M-428% | ||
| $403K-49.8% | $802K-40.3% | $1.34M+651% | $179K+25.2% | $143K-78.8% | ||
| $489.48M— | —— | —— | —— | $0— | ||
| -$268.65M-222% | -$83.49M-715% | $13.57M-53.4% | $29.13M+7.5% | $27.1M+52.2% | ||
| $400M— | —— | —— | —— | $0— | ||
| $412.55M+289% | -$217.96M-271% | -$58.81M+20.2% | -$73.69M-14,029% | $529K+113% | ||
| $82.04M+958% | -$9.56M-134% | -$4.09M-115% | -$1.9M-440% | $558K— | ||
| -$62.19M-121% | $291.16M+623% | $40.28M-2.0% | $41.12M+249% | -$27.66M-370% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioCryst Pharmaceuticals generate?
- BioCryst Pharmaceuticals (BCRX) generated $313.1M in operating cash flow over the trailing twelve months.
- What is BioCryst Pharmaceuticals's free cash flow?
- After $2.7M of capital expenditures, BioCryst Pharmaceuticals's free cash flow was $310.4M over the trailing twelve months, up 448.8% year over year.
- Where does BioCryst Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
